ArticleFrontiers in endocrinology2025
Association between the triglyceride-glucose index and hyperuricemia in patients with type 2 diabetes mellitus.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and risk factors of hyperuricemia and gout in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Nonlinear Association of the Triglyceride-Glucose Index With Hyperuricemia Among Young Chinese Adults.Journal of clinical hypertension (Greenwich, Conn.) · 2026Article
- Association between TyHGB and hyperuricemia and gout in patients with type-2 diabetes mellitus.BMC endocrine disorders · 2026Article
- Association between the Zhejiang University index and hyperuricemia among adults with type 2 diabetes in China.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: This cross-sectional study investigated the relationship between the triglyceride-glucose (TyG: A surrogate marker for assessing insulin resistance.) index and hyperuricemia (HUA: Metabolic diseases caused by purine metabolism disorders.) risk in Chinese patients with type 2 diabetes mellitus (T2DM). Methods: From January 2021 to December 2023, T2DM patients were enrolled from Luhe District People's Hospital in Nanjing. Participants were stratified by TyG index quartiles. Logistic regression and restricted cubic spline (RCS) analyses assessed the TyG-HUA association. Results: This study included 996 participants with type 2 diabetes, with a male predominance of 54.82%, a mean age of 60.39 years, and a median TyG index of 7.63. Compared to the lowest TyG quartile, the highest quartile exhibited a 4.23-fold (95% CI: 1.46 ~ 12.24, P value = 0.008) increased HUA risk. Restricted cubic spline analysis revealed a nonlinear relationship between the TyG index and HUA (nonlinear P value = 0.044). As the TyG level increased, the risk of HUA initially rose and then showed a downward trend (P for TyG = 0.008). Conclusions: Elevated TyG index independently predicts HUA risk in T2DM patients. Early metabolic intervention may mitigate HUA-related cardiovascular morbidity and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.